Mylan Pharmaceuticals Inc. et al. v. Regeneron Pharmaceuticals, Inc. > Summary
Court Case Number IPR2023-00099
Filing Date Oct 28, 2022
Institution Decision Date Mar 1, 2023
Decision Date Mar 1, 2023
Court Patent Trial and Appeal Board
Status Institution Denied
Administrative JudgesErica A. Franklin, Ryan H. Flax, Jamie T. Wisz
Judge Writing the Final DecisionErica A. Franklin
Claims Challenged in the Petition: 1, 2, 3
Claims Instituted: 1, 2, 3
Petitioner
Patent Owner
Petitioner Attorneys
11Viatris Inc.
Attorney Name: Paul John Molino
Rakoczy Molino Mazzochi Siwik
Viatris Inc.
Attorney Name: Heinz J. Salmen
Rakoczy Molino Mazzochi Siwik
Viatris Inc.
Attorney Name: William A. Rakoczy
Rakoczy Molino Mazzochi Siwik
Viatris Inc.
Attorney Name: Deanne M. Mazzochi
Rakoczy Molino Mazzochi Siwik
Viatris Inc.
Attorney Name: Neil B. McLaughlin
Rakoczy Molino Mazzochi Siwik
Viatris Inc.
Attorney Name: Eric R. Hunt
Rakoczy Molino Mazzochi Siwik
Viatris Inc.
Attorney Name: Jeffrey A. Marx
Rakoczy Molino Mazzochi Siwik
Viatris Inc.
Attorney Name: Lauren M. Lesko
Rakoczy Molino Mazzochi Siwik
Viatris Inc.
Attorney Name: Scott G. Bell
Rakoczy Molino Mazzochi Siwik
Viatris Inc.
Attorney Name: Steven J. Birkos
Rakoczy Molino Mazzochi Siwik
Viatris Inc.
Attorney Name: Thomas H. Ehrich
Rakoczy Molino Mazzochi Siwik
Patent Owner Attorneys
4Regeneron Pharmaceuticals
Attorney Name: Daralyn J. Durie
Morrison & Foerster
Regeneron Pharmaceuticals
Attorney Name: Adam R. Brausa
Morrison & Foerster
Regeneron Pharmaceuticals
Attorney Name: Rebecca E. Weires
Morrison & Foerster
Regeneron Pharmaceuticals
Attorney Name: Kira A. Davis
Morrison & Foerster
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 10857205 | Use of a VEGF antagonist to treat angiogenic eye disorders | Dec 8, 2020 |
